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Detection of cyclic-di-adenosine monophosphate (c-di-AMP), a bacterial second messenger, by the host cytoplasmic surveillance pathway (CSP) is known to elicit type I interferon (IFN) responses, which are crucial to antimicrobial defense [1] [2] [3] . However, the mechanisms and role of c-di-AMP signaling in Mycobacterium tuberculosis virulence remain unclear. Here we show that resistance to tuberculosis requires CSP-mediated detection of c-di-AMP produced by M. tuberculosis and that levels of c-di-AMP modulate the fate of infection. We found that a di-adenylate cyclase (disA or dacA) 4 -overexpressing M. tuberculosis strain that secretes excess c-di-AMP activates the interferon regulatory factor (IRF) pathway with enhanced levels of IFN-b, elicits increased macrophage autophagy, and exhibits substantial virulence attenuation in mice. We show that c-di-AMP-mediated IFN-b induction during M. tuberculosis infection requires stimulator of interferon genes (STING) 5 -signaling. We observed that c-di-AMP induction of IFN-b is independent of the cytosolic nucleic acid receptor cyclic GMP-AMP (cGAMP) synthase (cGAS) 6, 7 , but cGAS nevertheless contributes substantially to the overall IFN-b response to M. tuberculosis infection. In sum, our results reveal c-di-AMP to be a key mycobacterial pathogen-associated molecular pattern (PAMP) driving host type I IFN responses and autophagy. These findings suggest that modulating the levels of this small molecule may lead to novel immunotherapeutic strategies against tuberculosis. The innate immune system is crucial to the early detection of invading pathogens, and it functions by recognizing specific PAMPs via germline-encoded pattern-recognition receptors (PRRs) 8 . Downstream signaling after PRR and ligand binding leads to the elicitation of innate immune responses and subsequent modulation of the adaptive responses, thereby orchestrating a complex network of host defenses 8 . Cyclic dinucleotides (CDNs), which are either produced by invading bacterial pathogens (such as c-di-AMP and c-di-GMP) or produced endogenously in response to foreign DNA (cGAMP) represent one such category of small molecules that, during infection, act as triggers for innate immune responses leading to induction of type I interferons (IFN-α/β) 2, 6, 9 . CDNs trigger type I IFN induction through Toll-like receptor (TLR)-independent pathways 9 that include direct interaction with the endoplasmic reticulum (ER) membrane protein STING or the cytosolic receptor DDX41, which complexes with STING and triggers signal activation via phosphorylation of TANKbinding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) 5, 10 . Although the potency of cytosolic signaling induced by CDNs and dsDNA appears comparable 9 , the sensors may differ in their target specificities 10, 11 . Of the several putative mammalian cytosolic DNA sensors that signal through STING 12 , cGAS has recently been shown to be essential for DNA-mediated immune responses, irrespective of cell type and nucleic acid sequence 11 . On detection of foreign nucleic acid, cGAS synthesizes a noncanonical CDN, cGAMP, which subsequently binds to STING, thereby leading to induction of type I IFNs via the same signaling axis as that used by bacterial CDNs 11 . The production of a host-generated CDN in response to foreign nucleic acid may account for the apparent overlap of the responses to the structurally distinct ligands.
Similarly to several pathogenic bacteria, the M. tuberculosis genome encodes a di-adenylate cyclase enzyme (disA, also called dacA; encoded by gene Rv3586 in the H37Rv genome or MT3692 in the CDC1551 genome) that synthesizes c-di-AMP from ATP or ADP 4 . Orthologs of disA exist in all mycobacterial genomes with the exception of M. leprae. However, the role of c-di-AMP in M. tuberculosis physiology and mechanism of its interaction with the host immune system is poorly understood 13, 14 . Evidence from other intracellular bacterial infections strongly suggests that both microbial DNA and CDNs stimulate the secretion of type I IFNs 2,15 . However, the existing model for M. tuberculosis infection hypothesizes that extracellular mycobacterial DNA is the only ligand for CSP activation within macrophages, which leads to increased autophagy and bacterial clearance in an ESX-1 secretion system-dependent manner, excluding any role for bacterial CDNs in CSP activation 16, 17 . Here we report that c-di-AMP, not cytosolic DNA alone, is a crucial ligand for CSP activation, leading to induction of type I IFNs and autophagy during M. tuberculosis infection.
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To confirm that M. tuberculosis produces and secretes c-di-AMP, we first detected and quantified bacterial c-di-AMP production in 7H9 broth culture and found considerable levels in both the intracellular and extracellular compartments by using highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS)/multiple reaction monitoring (MRM) methods ( Supplementary Fig. 1a,b) . We also observed that intracellular c-di-AMP levels increase during the late-log and stationary phases of growth of M. tuberculosis compared to early log-phase growth (Supplementary Fig. 1c ). We also detected further M. tuberculosis-produced c-di-AMP in the infected macrophage cytosol (Supplementary Fig. 1d ). Next, we constructed a recombinant M. tuberculosis strain overexpressing its endogenous di-adenylate cyclase gene, disA (M. tuberculosis (Mtb)-overexpressing (OE) strain) ( Supplementary Fig. 2a,b) . Analysis of the transcriptome by mRNA sequencing revealed a 95-fold overexpression of disA in the Mtb-OE strain compared to the M. tuberculosis CDC1551 wild-type (WT) control strain ( Supplementary Fig. 2c) , with a resultant ~20-fold increase in the production of c-di-AMP ( Supplementary  Fig. 2d ). The absence of any c-di-AMP in the mutant bacterial strain ( Supplementary Fig. 3 ) with a transposon insertion disrupting the di-adenylate cyclase domain of disA ( Supplementary Table 1 ) confirms that c-di-AMP is produced by a single di-adenylate cyclase in M. tuberculosis. Complementation of the mutant bacteria with its endogenous disA gene and native promoter reconstituted c-di-AMP production (Mtb-COMP strain) ( Supplementary Fig. 4 ).
To investigate whether perturbations of c-di-AMP levels in M. tuberculosis influence host type I IFN responses, we infected J774.1 mouse macrophage cells with M. tuberculosis strains expressing different c-di-AMP levels, and measured IFN-β levels by ELISA at 24 h after infection. Infection with the Mtb-disA-knockout (KO) strain (in which the disA gene was disrupted) resulted in a significant reduction in IFN-β induction by J774.1 cells compared to infection with the wild-type M. tuberculosis CDC1551 strain (Mtb-WT) ( Fig. 1a,b) . Conversely, infection with the Mtb-OE strain resulted in an enhanced induction of IFN-β by both resting and activated J774.1 cells. Notably, Mtb-OE-infected cells also secreted significantly higher levels of tumor necrosis factor (TNF)-α compared to the Mtb-WT infected cells, whereas Mtb-disA-KO-infected cells produced lower TNF-α levels compared to other groups (Fig. 1c,d) . Moreover, the patterns of IRF pathway activation in THP1 human monocyte cells (Supplementary Fig. 5 ) and IFN-β responses in mouse primary bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs) ( Fig. 1e,f) were comparable, further confirming our hypothesis. However, we noticed that mouse BMDCs are a comparatively better IFN-β producer than BMDMs in response to M. tuberculosis infection, which has also been reported by others 18 . Induction of IFN-β was further confirmed by real-time reversetranscription quantitative PCR (RT-qPCR) of the BMDC cells infected with various M. tuberculosis strains ( Fig. 1g) . We also observed induction of significantly higher levels of pro-inflammatory cytokines including interleukin (IL)-1α, IL-6 and TNF-α by both BMDMs and BMDCs after infection with the c-di-AMP-overexpressing M. tuberculosis strain ( Supplementary Fig. 6 ). These observations suggest that perturbation of c-di-AMP levels in M. tuberculosis not only influences the CSP-mediated type I IFN response but also has a crucial role in modulating the pro-inflammatory cytokine signature of the infected cells.
Taking into account the ambiguous role of the type I IFN response in host control of tuberculosis, we monitored the growth patterns of these M. tuberculosis strains in resting and IFN-γ/lipopolysaccharide (LPS)-activated J774.1 cells. Whereas all M. tuberculosis WT and recombinant strains showed identical growth rates in 7H9 broth culture ( Supplementary Fig. 7) , the Mtb-OE strain exhibited significantly diminished intracellular growth compared with the other M. tuberculosis strains ( Fig. 1h,i) . We did not notice any growth attenuation of the Mtb-disA-KO strain. These observations reveal that overexpression of c-di-AMP by M. tuberculosis results in marked attenuation of the intracellular growth of the Mtb-OE strain.
In light of reports indicating that CDNs are potent autophagy inducers 16, 19 , we investigated whether enhanced macrophage autophagy might account for the attenuation of the c-di-AMP-overexpressing Fluorescence confocal imaging demonstrated a considerably higher percentage of cells (~15%) showing LC3 puncta formation in Mtb-OE infection compared to Mtb-WT (~10%) and Mtb-disA-KO infections (~6%) ( Fig. 2a,b ). In addition, western blot analysis of endogenous LC3 revealed an increase in conversion of LC3-I to LC3-II in the Mtb-OE-infected cells, indicating hyperactivation of autophagy ( Fig. 2c) . We also observed a considerably higher percentage of pTBK1-positive cells, suggesting activation of the IRF pathway 5, 10 in the Mtb-OE-infected J774.1 cells ( Supplementary Fig. 8 ). These observations strongly suggest that hyperinduction of autophagy by macrophages may be one of the contributing factors that restricts the intracellular growth of the Mtb-OE strain. Next we examined the virulence and pathogenicity of the M. tuberculosis strains in mouse aerosol infection models. Remarkably, compared to WT infection (median time to death (MTD) of 150 d), we observed a significant increase in the survival of Mtb-OE-infected mice (MTD 321 d) ( Fig. 3a) . In contrast, the Mtb-disA-KO strain, which is c-di-AMP deficient, showed reduced survival with an MTD of 77 d ( Fig. 3a) . Concomitantly, the Mtb-OE strain also exhibited growth attenuation as evidenced by significantly reduced lung and spleen bacillary loads (Fig. 3b,c) . Gross and histopathological findings of mouse lungs and spleens correlated well with the bacterial organ burden observations ( Fig. 3d,e ). The lungs of Mtb-OE-infected mice showed significantly fewer and smaller tubercle-like lesions compared to other groups (Fig. 3d,e ). Concordantly, although Mtb-WT-, Mtb-disA-KO-, and Mtb-COMP strain-infected mice exhibited considerable splenomegaly, spleens of the Mtb-OE-infected mice appeared normal in size ( Fig. 3d) . Together, these observations clearly demonstrate attenuation of virulence in the c-di-AMP-overexpressing M. tuberculosis strain.
Next, we compared the mouse serum cytokine levels between these groups at an early stage of disease: 2 weeks after infection. Consistent with our in vitro studies in mouse and human cells, we observed increased IFN-β levels in the serum of Mtb-OE-infected mice compared to the Mtb-WT and Mtb-disA-KO groups (Fig. 3f) .
In addition, the Mtb-OE group exhibited significantly higher serum levels of TNF-α ( Fig. 3g) . Because type I IFN (IFN-β) is known to counter-regulate type II IFN (IFN-γ) responses 20 , we measured IFN-γ levels in the serum of infected mice (Fig. 3h) . We observed a strong inverse relationship between IFN-β and IFN-γ in these mice, corresponding to the ability of the M. tuberculosis-strains to produce c-di-AMP.
Our studies reveal that bacterial c-di-AMP levels are strongly associated with the immunopathological outcome of M. tuberculosis infection in mice. Hence, we next examined the host cytosolic sensors that may detect M. tuberculosis-derived c-di-AMP, starting with helicase DDX41, a cytosolic DNA and CDN receptor that signals via STING 10, 21 . We performed shRNA-mediated knockdown of DDX41 using RAW-Blue ISG cells (InvivoGen) that allow colorimetric measurement of the induction of the IRF pathway. Knockdown of DDX41 caused a substantial decrease in activation of the IRF pathway and reduced IFN-β induction after infection with all the M. tuberculosis strains (Supplementary Fig. 9a-c) . We also observed a significantly reduced TNF-α production by the DDX41knockdown cells (Supplementary Fig. 9d ). These results suggest that DDX41 is a key PRR for both DNA and c-di-AMP, and that DDX41 regulates the induction of both type I IFNs and TNF-α after M. tuberculosis infection.
We then investigated the contribution of STING to the c-di-AMPmediated IFN-β response during M. tuberculosis infection. A partial knockdown of STING in human THP1 cells showed considerably lower IFN-β induction than in control cells after infection with various M. tuberculosis strains (Supplementary Fig. 10 ). Moreover, all M. tuberculosis strains failed to activate the IRF pathway or induce IFN-β in mouse RAW 264.7 macrophage IRF reporter cells lacking STING (STING-KO) ( Fig. 4a-d) . However, LPS, which stimulates type I IFN through STING-independent pathways, induced elevated IFN-β response even in STING-KO cells (Fig. 4a,b) . These results confirm that, in addition to its role in bacterial DNA-mediated responses, STING is an essential component for c-di-AMP-mediated activation of the IRF pathway during M. tuberculosis infection 17 . Furthermore, infection of macrophages with M. bovis bacillus Calmette-Guérin (BCG), which is known to lack the ESX-1 secretion system, also showed activation of the IRF pathway at 20-60% of the levels seen after infection with either the Mtb-WT (the CDC1551 strain) or the Erdman strain, a different WT M. tuberculosis strain considered to be highly virulent (Fig. 4a,b) . Notably, the c-di-AMP-overexpressing M. bovis BCG strain (BCG-OE) produced a significantly higher IRF and IFN-β response than M. bovis BCG itself, suggesting that bacteriaderived c-di-AMP gains access to the host cell cytosol despite the absence of an ESX-1 protein secretion system (Fig. 4a,b) . These experiments indicate that, although contributory to overall type I IFN response, ESX-1 may not be essential for c-di-AMP-triggered IRF pathway activation. However, further studies with isogenic M. tuberculosis strains lacking the ESX-1-secretion system may provide direct evidence for a contribution of the ESX-1 secretion system in c-di-AMP-mediated responses during M. tuberculosis infection.
Next we evaluated the role of cGAS in the detection of bacterial c-di-AMP. We infected primary BMDMs (Fig. 4e) and BMDCs (Fig. 4f ) from WT and cGAS-KO mice 22 with various mycobacterial strains and measured IFN-β protein levels. Although the loss of cGAS resulted in a considerably reduced IFN-β response compared to cells with intact cGAS (WT), all c-di-AMP-overproducing strains continued to show significantly higher induction of IFN-β in cGAS-KO cells compared to their respective WT mycobacterial strains (Fig. 4e,f) . Further, both WT and cGAS-KO BMDMs produced comparable levels of IFN-β after stimulation with synthetic c-di-AMP ( Fig. 4g) . Real-time RT-qPCR for IFN-β in BMDCs further confirmed these results (Fig. 4h) . These experiments show that whereas c-di-AMP is a key ligand for IFN-β induction irrespective of cGAS, a substantial part of the overall IFN-β response during M. tuberculosis infection is cGAS dependent and hence is probably due to bacterial DNA.
Our data thus reveal the involvement of c-di-AMP as an M. tuberculosis PAMP that triggers host cell IFN-β secretion and autophagy. These observations expand on earlier studies that suggested that mycobacterial DNA is the exclusive ligand for inducing the type I IFN response and that the bacterial ESX-1 secretion apparatus is required for CSP activation 17 . Our findings, which used multiple bacterial strains (the M. tuberculosis CDC1551 and Erdman strains, and M. bovis BCG) each modified to overexpress c-di-AMP and a variety of host phagocytic cells, including those lacking or weakly expressing important mediators of the CSP (STING, DDX41, and cGAS), consistently demonstrated that c-di-AMP, not bacterial DNA alone, is a key mediator of type I IFN responses. Supplementary Table 2 lists major differences in our methods compared with those of earlier studies and reveals that strain, host cell, and methodological differences may have allowed the importance of c-di-AMP to have been overlooked in earlier studies.
We considered the possibility that c-di-AMP-mediated changes in other bacterial antigens might affect type I IFN responses through nucleotide-binding oligomerization domain (NOD)-like receptor signaling as reported by Pandey et al. 23 . However, a recent study demonstrated that the enhanced type I IFN response caused by accumulation of c-di-AMP in a c-di-AMP-phosphodiesterase mutant of M. tuberculosis is independent of NOD signaling 24 . This report thus further supports our observations and highlights induction of type I IFN response by c-di-AMP. Moreover, several publications have also demonstrated that NOD signaling is dispensable for IRF activation during M. tuberculosis infection 17 . Thus, we believe that indirect effects of c-di-AMP on other bacterial PAMPs are unlikely to account for the IFN-β responses we observe. Moreover, the absence of any difference in the intrabacterial cAMP levels among different M. tuberculosis strains further ruled out any off-target effect of perturbed disA expression or c-di-AMP levels on cAMP, a known inducer of TNF-α (ref. 25) .
The enhanced type I IFN response consequent to overproduction of c-di-AMP we observed in this study markedly extends correlative observations in several studies with laboratory and clinical isolates of pathogenic bacteria 24, 26, 27 . Although type I IFNs are absolutely critical for resistance to viruses, there are conflicting reports as to whether the IFN-α/β response is beneficial or detrimental to the host during tuberculosis 28, 29 . For example, loss of the IFN-α receptor in knockout mice confers resistance to tuberculosis suggesting that type I IFN responses are counterproductive in tuberculosis 30 . In contrast, IFNα/β responses have been shown to enhance antigen crosspresentation in DCs and activation of cytolytic CD8 T cells, which are crucial to M. tuberculosis clearance 31, 32 , and the type I IFN response has also been shown to limit lung infectivity of M. tuberculosis in animals devoid of type II IFN 33 . Notably, human tuberculosis transcriptome analysis of peripheral blood also revealed upregulation of genes associated with both the type I and type II IFN responses, suggesting overlapping and dynamic roles of both types of IFN in tuberculosis pathogenesis 34 . Beyond induction of type I IFN, our study also found enhanced induction of several pro-inflammatory cytokines, including IL-1α, TNF-α and IL-6, which are believed to have protective roles during M. tuberculosis infection 35 . Autophagy is increasingly appreciated as a key mechanism by which macrophages kill intracellular M. tuberculosis 36 , and autophagy inducers such as vitamin D have also been identified as potential candidates for the treatment of HIV-tuberculosis co-infection 37 . Indeed, certain first-line tuberculosis drugs, isoniazid (INH) and pyrazinamide (PZA), may act in part by stimulating autophagy 38 . Mounting evidence also suggests that mycobacterial DNA 17 , bacterial CDNs such as c-di-AMP 16, 19 , and induction of the type I IFN 39 response itself are inducers of autophagy. Our observation of CDN activation of IRF signaling and autophagy is consistent with the emerging appreciation of cross-talk between these two pathways.
Whereas altered virulence and antibiotic resistance have been associated with mutation of genes encoding c-di-AMP cyclase and phosphodiesterase in several bacterial pathogens 28 , modulation of bacterial c-di-AMP levels has yet to be linked to variables in the clinical presentation of human tuberculosis. However, differences in the induction of IFN-β by clinical isolates of M. tuberculosis 40 and the presence of mutations in the adenylate cyclase (TB database: Rv3586) as well as phosphodiesterase (TB database: Rv2837c) genes in clinical strains of M. tuberculosis suggest a potential association of c-di-AMP levels with forms of human tuberculosis disease. This study reveals that c-di-AMP produced by M. tuberculosis is a PAMP that modulates type I IFN response during infection, and it may prompt future correlative human studies.
Our findings highlight the importance of c-di-AMP detection in the host's innate resistance to tuberculosis and reveal a previously unappreciated mechanism of CSP activation by bacterial CDNs during M. tuberculosis infection. The ability of a small molecule, c-di-AMP, to govern the outcome of intracellular infection suggests novel approaches for the treatment and prevention of tuberculosis as well as related diseases.
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Extraction of nucleotides from M. tuberculosis and detection and quantitation of c-di-AMP by LC-MS/MS/MRM. Nucleotide extraction for
LC-MS/MS were carried out as described 42 . Briefly, M. tuberculosis was grown to mid-log phase and harvested by quick centrifugation followed by resuspension in extraction buffer containing acetonitrile and methanol and water (2:2:1) and cXMP as an internal technical control. After a 15-min incubation and subsequent boiling at 100 °C for 10 min, the mixture was cooled down and extracted after quick centrifugation. Extraction was repeated twice as described above. Pooled samples were vacuum dried and resuspended in distilled water followed by detection and quantitation by LC-MS/MS MRM. Briefly, the chromatographic separation was performed on a Series 200 HPLC system (Perkin Elmer Instruments) and the analyte detection was performed on an API 3000 triple quadrupole mass spectrometer equipped with an electrospray ionization (ESI) source (Applied Biosystems Inc.) using MRM analysis in positive ionization mode. The following SRM transitions using a dwell time of 40 ms were detected: cXMP: +347.1/153 (quantifier), +341.7/136 (identifier) and c-di-AMP: +659.1/330.2 (quantifier) and +659/524 (identifier).
Extraction of nucleotides from macrophage cytoplasm and detection and quantitation of c-di-AMP by LC-MS/MS/MRM. J774.1 cells were cultured
in RPMI medium with 10% heat-inactivated FBS. Infections were carried out in either resting or IFN-γ− and LPS-activated J774.1 cells in six-well plates in triplicate. For infection, early log-phase cultures of various Mycobacterium tuberculosis strains were washed and diluted appropriately to predefined concentrations in antibiotic-free RPMI and were added to the J774.1 cells at a precalibrated MOI. The infection was allowed to continue for 4 h, following which extracellular bacteria were removed by washing the infected cells with DPBS thoroughly. After 24 h of infection, supernatants were removed and adherent macrophages were washed carefully with DPBS. Macrophages were lysed with the addition of 1 ml of 0.025% SDS (at this concentration of SDS, bacteria is not lysed) to each of the wells. Released bacilli were subsequently separated by centrifugation followed by filtration through a 0.2-µm membrane filter, and bacteria-free pooled macrophage cytoplasmic extracts were used for extraction of nucleotides and subsequent analysis by LC-MS/MS as described above.
Overexpression of MT3692 in M. tuberculosis. The disA gene of M. tuberculosis, MT3692, was PCR-amplified from M. tuberculosis CDC1551 chromosomal DNA using gene-specific primers, pSD5hsp60.MT3692(F) and pSD5hsp60. MT3692(R) (Supplementary Table 3) . The amplicons were cloned into the Mycobacterial expression vector pSD5-hsp60 at the NdeI and MluI restriction sites. The resulting construct pSD5-hsp60-MT3692 was sequenced and subsequently used to transform M. tuberculosis CDC1551 and recombinant clones were selected against kanamycin and confirmed by colony PCR using kanamycin gene-specific primers (Supplementary Table 3 ). Overexpression of MT3692 in the Mtb-OE strain was further confirmed by RNA sequencing of the Mtb-OE strain and measurement of c-di-AMP by LC-MS-MRM. Overexpression of MT3692 in the M. tuberculosis Erdman and M. bovis BCG strains were carried out using the same plasmid.
Construction of MT3692 complementation strain.
To complement the transposon mutant for MT3692, a 279-bp DNA fragment including the coding sequence of the MT3692 gene and 1,714 bp of the 5′ sequence (including the upstream gene in the operon and gene's native promoter) was amplified by PCR with primers OPE-MT3692(F) and OPE-MT3692(R) ( Supplementary  Table 3 ) and cloned into an integretion vector, pMH94Hyg, at an XbaI restriction site. The resulting construct, pMH94Hyg-MT3692, was subjected to nucleotide sequencing and subsequently used to transform the Mtb-disA-KO strain. Candidate Hygromycin resistant Mtb-COMP colonies were selected, confirmed by PCR using hygromycin gene-specific primers ( Supplementary  Table 3 ) and genomic DNA as template. Mtb-COMP clones were further confirmed by measurement of c-di-AMP by LC-MS/MRM method.
Infection of mice with M. tuberculosis and assessment of bacterial load, pathology and time to death. Four strains of M. tuberculosis, Mtb-disA-KO, Mtb-COMP, Mtb-OE and Mtb-WT were used to infect 6-7-week-old female C57BL/6J mice by the aerosol route in a Glascol inhalation exposure system (Glascol) with an inoculum that implanted ~3.0 Log 10 c.f.u. in the lungs at day 1 (n = 3 mice in each group). Animals from a narrow range of weight and age groups were randomly allocated for infection with different bacterial strains. Eight mice from each group were subsequently sacrificed at 2, 4, 8 and 12 weeks after infection to determine the lung and spleen c.f.u. counts (n = 4) and histopathology and immunology studies (n = 4). Lung and spleen tissues were homogenized in their entirety in PBS and colonies were enumerated on selective 7H11 plates after 3-4 weeks of incubation at 37 °C. The number of colonies were counted and expressed as log 10 c.f.u. per organ. All groups were coded during the experiments. For histopathology, whole lungs were fixed in 10% buffered formalin and sections of 5 µm in thickness from formalin fixed and paraffin embedded tissues were cut onto glass slides and stained with H&E for histopathological examination. For time to death assay 6-7-week-old female BALB/c mice (n = 10 per group) were infected as described above with ~3.5 log 10 c.f.u. of various strains of M. tuberculosis and monitored until their death due to tuberculosis. All experiments were carried out according to the guidelines of the Institutional Animal Care and Use Committees (IACUCs) of Johns Hopkins University.
Infection of macrophages with M. tuberculosis and assay for IRF activation
and IFN-b production. J774.1 cells were cultured in RPMI medium with 10% heat-inactivated FBS. Infections were carried out in either resting or IFN-γand LPS-activated J774.1 cells in 24-well plates in triplicate. For infection, early log-phase cultures of various M. tuberculosis strains were washed and diluted appropriately to predefined concentrations in antibiotic-free RPMI and were added to the J774.1 cells at a precalibrated MOI. The infection was allowed to continue for 4 h, following which extracellular bacteria were removed by npg
